AzTrials
AzTrials

Death RecordsCANDELSNCT06910176

Confirming And Notifying Death

An observational study of Death Records, run by University Hospital, Strasbourg, France at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Most physicians are confronted with the death of patients during their practice, often as early as residency. It is their legal responsibility to certify a patient's death, as well as often to notify their loved ones. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Death Records
How many people
20 participants
Where
1 siteFrance
Study dates
10 Oct 2024to 10 Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Student having taken the national ECOS (thus becoming an intern at the start of the following academic year in November 2024),

Who may be able to join

  • DFASM3 student,
  • At the Faculty of Medicine of Strasbourg, France, for the 2023-2024 academic year,
  • Having taken the national ECOS (thus becoming an intern at the start of the following academic year in November 2024),
  • Aged 18 years or older,
  • Not opposed to participating in the study.
  • Not having completed an internship in specialized palliative care facilities

Who cannot join

  • Refused to participate in the study.
  • Not having taken the national ECOS.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Catherine CHEVALIER-LAMOUILLE, MD contact

33 3 88 11 65 86

catherine.lamouille@chru-strasbourg.fr

France1 site, 1 recruiting
  • Service de soins Palliatifs - CHU de Strasbourg - France

    Strasbourg, 67091

    Catherine CHEVALIER-LAMOUILLE, MD, 33 3 88 11 65 86, catherine.lamouille@chru-strasbourg.fr

    Catherine CHEVALIER-LAMOUILLE, MD

    Recruiting

Other trials in France

About this study

Official title: Confirming And Notifying Death : Blended Learning and Its Evaluation by Medical Students, an Acceptability Study"

Most physicians are confronted with the death of patients during their practice, often as early as residency. It is their legal responsibility to certify a patient's death, as well as often to notify their loved ones.

Yet, these duties currently receive little or no specific training during the various cycles of medical education.

This task is not easy, however, and young professionals experience it with difficulty. Literature data show that residents are confronted with death late in their medical education and that they are insufficiently prepared when they have to perform their first death certificate. Indeed, residents report significantly correlated practical and emotional difficulties. These difficulties are notably linked to a feeling of lack of preparation through theoretical courses, a lack of familiarity with administrative procedures, and insufficient mastery of communicating with families. The highlighting of these difficulties and the desire for appropriate and respectful care for the deceased and their families, for whom the moment of announcement influences the experience of grief, call for an improvement in teaching on these topics. It is in this sense that the project was born to explore whether the creation of training, before their independent exposure to death and its announcement, i.e. at the end of the second cycle, was relevant. A prerequisite for this type of training project is indeed to question the acceptability of such an approach by students.

Conditions
Death Records
Keywords
Notifying Death, Death Records

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To assess the acceptability of training in death certification and death notification to relatives by DFASM3 students in Strasbourg.

    Measured: At 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2025
  2. Study start10 Oct 2024
  3. Primary completion10 Dec 2025 (estimated)
  4. Study completion10 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06910176
Sponsor's protocol ID
9304
Acronym
CANDELS
Status last verified
Mar 2025
First submitted
27 Mar 2025
Last updated
26 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Death Records, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Catherine CHEVALIER-LAMOUILLE, MD (33 3 88 11 65 86, catherine.lamouille@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To assess the acceptability of training in death certification and death notification to relatives by DFASM3 students in Strasbourg. (time frame: At 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in